Value Strategy Outpaces S&P 500 for 5 Years

Lead paragraph

A concentrated value-stock strategy has outperformed the S&P 500 over a near five-year window ending March 25, 2026, according to a MarketWatch report published that day (MarketWatch, Mar 25, 2026). The result runs counter to the common expectation that value incurs lower returns than the broad market over long horizons; instead it highlights persistent cyclical and structural drivers that can shift factor performance materially across multi-year periods. This piece presents a data-centered assessment of that performance, situating the MarketWatch finding in long-run factor research, calendar-year market returns, and practical portfolio implications for institutional investors. Readers will find temporal breakdowns, benchmark comparisons, sector-level drivers and a frank appraisal of risks and implementation friction.

Context

The claim of outperformance covered in MarketWatch refers to a period described as "nearly five years" through March 25, 2026; in calendar terms this approximates the interval from Q2 2021 to Q1 2026 (MarketWatch, Mar 25, 2026). That episode spans several macro regimes: post-COVID reopening, supply-chain normalization, a 2022 equity drawdown, and a subsequent cyclical rotation back into value-sensitive sectors. For context, the S&P 500 posted +26.9% in 2021, -19.4% in 2022 and +26.3% in 2023 (S&P Dow Jones Indices); those calendar swings help explain concentrated deviations between factor strategies and the broad-cap benchmark.

Value as a distinct systematic factor is not new; the academic architecture around value dates to Fama and French's seminal 1992 paper, which formalized a value premium observable across US equities and international samples (Fama & French, 1992). Institutional adoption of value-oriented mandates and factor-tilt ETFs widened over the subsequent three decades, but practical implementation varies: screening by price/book or price/earnings, sector constraints, and active share lead to materially different realized returns versus academic factor returns. The MarketWatch piece features one particular strategy with a specific selection and weighting scheme; it is important not to conflate that single-strategy result with every value mandate.

Investors should also note the benchmark composition: the S&P 500 comprises 500 large-cap companies and is market-cap weighted (S&P Dow Jones Indices). A cap-weighted index will overweight richly valued, fast-growing mega-cap names in expansion phases and underweight value-oriented, cyclically sensitive firms—this structural feature is a core driver of divergence between a value strategy and the S&P 500 during multi-year rotations.

Data Deep Dive

Three concrete numeric anchors are central to understanding the claim. First, the MarketWatch article documenting the strategy's multi-year outperformance was published on March 25, 2026 (MarketWatch, Mar 25, 2026). Second, the underlying timeframe is roughly 60 months (five years) leading to that date, a span long enough for factor regimes to rotate but short relative to a full market cycle. Third, the S&P 500 produced highly non-linear annual returns over the interval—illustrative years include +26.9% (2021), -19.4% (2022), and +26.3% (2023)—data points that punctuate why concentrated factor strategies can diverge materially from the benchmark (S&P Dow Jones Indices).

Beyond raw returns, risk-adjusted measures and drawdown profiles matter. A strategy that outperforms the S&P 500 in total return may still have either higher volatility or deeper drawdowns in certain windows; neither the MarketWatch summary nor the headline claim substitutes for an analysis of Sharpe ratios, sortino ratios, or maximum drawdown. Institutional investors should request time-series data to calculate annualized volatility, information ratio versus the S&P 500, and peak-to-trough loss periods. Those risk metrics determine whether outperformance is compensation for incremental beta, for concentrated idiosyncratic bets, or for genuine factor premium capture.

A final datapoint: the historic academic literature dating to Fama & French (1992) and extended in subsequent work has documented a value premium across decades, but the magnitude varies by sample and period (Fama & French, 1992). Implementation differences—screen definitions, rebalancing frequency, and sector neutralization—explain why a published strategy can "trounce" the S&P 500 for a particular five-year interval while other value approaches lag.

Sector Implications

The recent value outperformance is tightly linked to sector composition. Value strategies often overweight financials, industrials, energy and certain consumer staples relative to a growth-heavy large-cap benchmark. During commodity price rebounds and rising interest rate environments, these sectors can outperform materially. For example, cyclical recovery in 2023–2025 favored manufacturing- and commodity-exposed names, which historically trade on lower multiples and provide earnings resilience when real rates normalize.

Conversely, the S&P 500's largest weights are frequently technology and communication services, sectors that benefited from a low-rate regime and durable secular growth narratives in the preceding decade. When those narratives slow and macro volatility rises, cap-weighted exposure to a few mega-caps can depress benchmark-relative returns even if the index's headline return is positive. The interaction of sector concentration and macro transitions explains much of the divergence between the featured value strategy and the broad-market benchmark.

For institutional allocators, sector effects imply implementation choices: a value tilt with sector neutrality will produce different active bets versus an unconstrained value screen. Tactical overweight to energy or financials delivers higher cyclical beta; sector-neutral screens isolate valuation dispersion within sectors and can produce lower correlation to macro cycles. Our research library and value investing research explain trade-offs in construction and the historical performance of sector-neutral versus sector-unconstrained value approaches.

Risk Assessment

Outperformance over a specific five-year horizon introduces three key risk questions for allocators: persistence, concentration, and implementation drag. Persistence asks whether the observed outperformance is likely to continue; factor regimes historically mean-revert and can underperform for multi-year stretches—as value did for large portions of the 2010s. A single five-year observation is informative but not definitive about long-term persistence. Institutional investors must evaluate whether observed returns reflect durable economic exposure or a timing-specific opportunity.

Concentration risk matters because many value strategies employ concentrated portfolios of high-conviction names; such concentration amplifies both upside and idiosyncratic downside. The MarketWatch article highlights a specific value strategy, and its winners may include a handful of stocks responsible for a disproportionate share of excess returns. Due diligence should include position-level attribution and stress testing for company-specific events. An allocation that overweights a handful of firms can generate headline outperformance while substantially increasing tracking error versus the benchmark.

Implementation drag—transaction costs, turnover, and tax implications—can erode realized performance relative to backtested or headline figures. Value strategies that rely on frequent rebalancing or active entry/exit decisions may face meaningful trading costs in illiquid small-cap or microcap segments. Institutional investors need to model net-of-fees and net-of-costs returns; see our market insights for white papers on transaction-cost analysis and implementation best practices.

Outlook

Looking forward, several macro variables will determine whether a value tilt continues to be a source of excess return: real interest rates, growth momentum, inflation trajectory, and corporate earnings dispersion. If real yields stabilize or rise modestly, and if earnings growth becomes more concentrated in cyclical sectors, value-sensitive stocks should retain an advantage. A pivot back to secular growth dominance or a disinflationary shock that re-rates long-duration assets would reverse those dynamics.

Time horizons also matter. For long-term strategic allocations, the historical record suggests that diversification across factors plus active monitoring of valuation extremes is prudent. For tactical allocations, a disciplined value screen timed to macro and micro valuation signals can harvest period-specific premiums but requires rigorous risk controls. Institutional investors must calibrate allocation size, rebalancing cadence, and mandate constraints to align with return-seeking objectives and risk tolerances.

Fazen Capital Perspective

Fazen Capital views the MarketWatch finding as a useful reminder that factor outcomes are path-dependent and sensitive to macro regime shifts; however, we caution against extrapolating a single strategy's five-year success into a blanket endorsement of all value implementations. Contrarian edge comes from recognizing that outperformance during a cyclical regime does not guarantee persistent alpha—especially if the strategy carries concentrated sector exposure or relies on low-turnover rebalancing that can trap winners or losers.

A less obvious insight is that value's recent resurgence has been partly structural: higher dispersion of earnings across mid-cap cyclicals has widened the opportunity set for bottom-up value screens, which historically perform better when dispersion is high. That suggests allocators who can implement value exposure with tight cost controls and disciplined risk management—using sector-aware screens or volatility-aware weighting—may access superior risk-adjusted returns versus naive cap-weighted implementations.

Finally, we emphasize implementation parity: two firms can claim "value" yet deliver wildly different realized outcomes. Institutional investors should request granular attribution, turnover statistics, tax-cost modeling, and scenario-based stress tests before increasing allocation to any single value strategy. Our actionable research on screening techniques and trade execution is available in our insights hub at value investing research.

Bottom Line

A particular value-stock strategy did outperform the S&P 500 over roughly five years to March 25, 2026, but institutional investors should treat that result as one input—requiring deeper attribution, risk analysis, and implementation scrutiny—rather than conclusive evidence that all value mandates will persistently beat the benchmark.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.

FAQ

Q: How should an institutional investor evaluate whether the outperformance is repeatable?

A: Ask for rolling return series, annualized volatility, Sharpe and information ratios, and position-level attribution across the full period; examine turnover, average holding period and transaction-cost estimates, and test performance in worst-case drawdown windows to assess repeatability.

Q: Has value historically outperformed over multi-decade horizons?

A: Academic work beginning with Fama & French (1992) documents a long-run value premium in many samples, but the magnitude and persistence vary by region and sample period. Value has endured long intervals of underperformance—decadal stretches in the 2010s are a salient example—so multi-decade extrapolations require careful probabilistic framing.